COPD Patients Need More Education on Wildfire Smoke Risks
New research suggests COPD patients lack critical information and clinical guidance to manage respiratory risks during wildfire events.
New research suggests COPD patients lack critical information and clinical guidance to manage respiratory risks during wildfire events.
Phase 3 trial results indicate a new antifungal medication olorofim is as effective as current standard treatments for invasive aspergillosis with fewer side effects.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
ENA Respiratory received notices of allowance for two US patents covering its innate immune modulators and their application in preventing COPD exacerbations.
A total of 2,073 measles cases have been reported in the United States in 2026 -- nearly as many as 2025, which was the worst year for measles infections since 1991.
Rextovy, a 4 mg naloxone medication, will be available for purchase without a prescription at retail stores and online.
Patients experiencing both excessive daytime sleepiness and prolonged sleep-onset latency face a significantly higher risk of hypertension.
Women's attitudes and beliefs regarding sleep during pregnancy are significant predictors of sleep disruption after delivery.